Company news

Prothena Corporation plc news in 2025

Prothena Corporation plc's news releases, calls and decks from 2025, newest first.

View company

Prothena Announces Board of Directors Update

December 12, 2025

Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025

November 19, 2025

Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA

November 11, 2025

Prothena Reports Third Quarter 2025 Financial Results and Business Highlights

November 8, 2025

Prothena Reports Third Quarter 2025 Financial Results and Business Highlights

November 6, 2025

Prothena to Report Third Quarter 2025 Financial Results on November 6

October 30, 2025

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease

October 1, 2025

Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference

August 28, 2025

Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program

August 27, 2025

Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy

August 6, 2025

Prothena Reports Second Quarter 2025 Financial Results and Business Highlights

August 4, 2025

Prothena to Report Second Quarter 2025 Financial Results on August 4

July 28, 2025

Prothena Announces Corporate Restructuring

June 18, 2025

Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease

June 16, 2025

Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint

May 23, 2025

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025

Prothena to Report First Quarter 2025 Financial Results on May 8

May 1, 2025

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

February 20, 2025

Calls in 2025

Decks in 2025